SUMMARY
Thioredoxins (Trx) are small ubiquitous proteins that participate in different cellular processes via redox-mediated reactions. We report here the identification and characterization of a novel member of the thioredoxin family in human, named Sptrx (sperm-specific trx), the first with a tissue-specific distribution, located exclusively in immunogold electron microscopy analysis demonstrated Sptrx localization in the cytoplasmic droplet of ejaculated sperm. Sptrx appears to have a multimeric structure in native conditions and is able to reduce insulin disulfide bonds in the presence of NADPH and thioredoxin reductase. During mammalian spermiogenesis in testis seminiferous tubules and later maturation in epididymis, extensive reorganization of disulfide bonds is required to stabilize cytoskeletal sperm structures. However, the molecular mechanisms that control these processes are not known. The identification of Sptrx with an expression pattern restricted to the post meiotic phase of spermatogenesis, when sperm tail is organized, suggests that Sptrx might be an important factor in regulating critical steps of human spermiogenesis.
INTRODUCTION
Thioredoxins (Trx) are low-molecular weight proteins (12 kDa) that catalyze thioldisulfide redox reactions by the reversible oxidation of the cysteine residues of their conserved active site WCGPC (1) . Thioredoxins are maintained in their active reduced form by the flavoenzyme thioredoxin reductase (TrxR) that uses the reducing power of NADPH, which constitutes the so-called thioredoxin system (2) . All the organisms from bacteria to human appear to have at least one complete thioredoxin system and the progressive complexity of eukaryotic organisms is also reflected in the increasing number of thioredoxin systems. Thus, E. coli contains two thioredoxins and one thioredoxin reductase; yeast has two thioredoxin systems, one in cytosol and the other one in mitochondria, and photosynthetic organisms have several thioredoxin systems in different cellular compartments including chloroplasts. Finally, mammalian cells have, at least, two thioredoxin systems located in the cytosol and mitochondria, respectively (3) . Different functions have been assigned to thioredoxins relying mostly on their general disulfide-reductase activity. In mammals, cytosolic Trx has been shown to be an antioxidant, a modulator of apoptosis, cell growth and differentiation and also a regulator of the DNA-binding activity of several transcription factors (following translocation into the nucleus), while the function of the mitochondrial thioredoxin system has not been yet elucidated although it is thought to constitute a major antioxidant defense mechanism. A common characteristic of both mammalian systems is their ubiquitous presence in all the tissues investigated within the same organism (3, 4) .
The human spermatozoon provides the male pronucleus for fertilization and to achieve this objective it has developed a highly specialized morphology organized into two major structures: the head and the tail or flagellum (5) . The head contains the highly condensed DNA contributed by the male and all the cellular components that ensure egg recognition and sperm-egg fusion while the flagellum is responsible for sperm motility and energy production for the propulsive apparatus (6, 7) . Mammalian sperm tail is divided into three main regions running in a proximal to distal direction away from the sperm head: the mid-piece (that is attached to the sperm head by the neck or connecting piece), the principal piece and the end piece (for a scheme on sperm tail organization see (7) and (8)). The flagellum of the mammalian spermatozoa is organized around the central axoneme which consists of 9+2 microtubules, similar to that seen in the cilia and flagella of all eukaryotic cells and extends through the full length of the flagellum (7). In addition, mammalian spermatozoa contain characteristic cytoskeletal elements associated with the axoneme, namely outer dense fibers (ODF) and fibrous sheath (FS), that do not have any counterparts in any other cell type (5).
ODF are adjacent to the axoneme and extend from the neck to the posterior end of the principal piece. In the middle piece, nine ODF (each one associated with one axonemal microtubule doublet) are surrounded by a helically wrapped mitochondrial sheath, that supplies the energy required for motility. This distribution pattern changes in the principal piece where FS replaces the mitochondrial sheath and the ODF number is reduced from nine to seven that progressively decrease in size. FS is composed of two longitudinal columns, running opposite to doublets 3 and 8 in replacement of the two missing ODF, connected by a series of ribs formed of closely packed filaments (5) . The function of ODF and FS is not fully elucidated but it seems to be related with the control of the flagellar motion (8) and protection against shearing forces during epididymal transit (9) . In recent years, the number of sperm-specific proteins has increased considerably although it is estimated that only 10-20% of the sperm polypeptides have been identified. The present work adds a new member to the list of sperm-specific proteins, the first belonging to the thioredoxin family.
EXPERIMENTAL PROCEDURES
cDNA cloning of human Sptrx gene. The Basic Local Alignment Search Tool (BLAST) (10) was used to identify human EST clone-encoded proteins similar to the ORF of human Trx1 or Trx2 (11, 12) . One of these EST entries (AA431210) was found to encode a putative novel human thioredoxin like protein. Based on this sequence, the nested primers hSptrx-R1/hSptrx-R2 (nucleotides 1653-1627 and 1605-1579, all nucleotide numbers referred to GenBank entry AF080095) and hSptrx-F4/hSptrx-F5 (nucleotides 1297-1320 and 1335-1359, respectively) were used for 5´-and 3´-RACE in a human testis cDNA library (Clontech) to isolate human Sptrx cDNA. The resulting sequences were used to amplify by PCR the full-length cDNA from the same library. and transformed in E. coli BL21(DE3). The induction of the fusion protein was performed as previously described (13) . Overexpressing cells were disrupted by 10 min sonication and the supernatant was cleared by centrifugation at 15,000 x g for 30 min
Northern blot analysis:
and loaded onto a glutathione sepharose 4B column (Pharmacia Biotech). Binding to the matrix was allowed to occur during 2 h at room temperature. Thrombin (5U per mg fusion protein) was used to remove GST by incubation overnight at 4°C. The resulting protein preparation was then subjected to ion exchange chromatography using a HiTrap Q column (Pharmacia Biotech) and human Sptrx was eluted using a gradient of NaCl. Protein concentration was determined from the absorbance at 280 nm assuming a molar extinction coefficient of 7690 M -1 cm -1 that was calculated using the Protean
Program included in the DNASTAR Software Package (DNASTAR Inc., Madison, USA). The cloning, overexpression and purification of the truncated form of human Sptrx (h∆Sptrx) was identical to that described for the full-length protein except that the ion exchange purification step was not required as the protein eluted in a pure form following thrombin cleavage.
Enzymatic activity assays.
Two different enzymatic assays were used to determine the ability of human Sptrx to reduce insulin in vitro. In the so-called DTT assay, DTT is used as reductant and the assay was carried out as previously described (11) . The other assay used thioredoxin reductase and NADPH as electron donors for thioredoxin and was performed essentially as described elsewhere (13) . In both cases human Trx1 was used as control.
Antibody production and immunoblotting analysis. Purified GST-hSptrx was used to immunize rabbits (Zeneca Research Biochemicals). After six immunizations, serum from rabbits was purified by ammonium sulfate precipitation. Affinity purified antibodies were prepared using a cyanogen bromide-activated Sepharose 4B column, onto which 0.5 mg recombinant N-terminal Sptrx fragment (lacking the thioredoxin domain) had been coupled using the procedure recommended by the manufacturer (Pharmacia). Specificity of the antibodies was tested by western blotting using human Sptrx cDNA) were used. All probes produced similar results when used separately and were usually used simultaneously to intensify the signal. Several control probes with the same length and similar GC content and specific activity were used to determine the specificity of the hybridization. In situ hybridization was carried out as described previously (14) .
For immunocytochemistry, paraffin sections containing multiple human tissues (T1065, Lot: 9994A) were obtained from Dako (Copenhagen). In addition routine paraffin sections of human testis were used. For immunofluorescence analysis human sperm samples were obtained from healthy volunteers.
Immunocytochemistry was performed as described previously (15) protein (19) , and a C-terminal domain (comprising the last 111 residues) similar to the previously described Trx1 and Trx2 (11, 12) . The N-terminal domain is characterized by a unique arrangement of residues organized as 23 repeats of a 15-residue motif shortly after the start methionine. As shown in Figure 1 , this motif has a general pattern Multiple-tissue Northern blots were used to determine the size and tissue distribution of human Sptrx mRNAs using the ORF as the probe. Human Sptrx mRNA was detected only in human testis as a single band of 1.7 kb in good agreement with the size of the cloned cDNA (Fig. 3A) . No signal was obtained in any other tissue after longer exposure. To evaluate the possibility that Sptrx mRNA could be expressed in other tissues not present in these blots, we also screened an RNA dot blot containing poly(A) + RNAs from 50 different human tissues. Among the tissues examined, hybridization signal was observed only in testis mRNA (Fig. 3B) .
A homology search in GenBank identified Sptrx genomic region in the genomic BAC clone AC006238. The main feature of human Sptrx gene is the lack of introns within the coding region and the presence of only one intron of 508 bp in the 5´-UTR (Fig. 4) . This intron, that interrupts the first in-frame 5´-UTR stop codon ( Fig. 1) , displays all the typical intron features as it conforms to the GT/AG rule and contains the splicing branch point consensus TGCTAAT and the downstream pyrimidine tract (Fig. 4) . Finally, the BAC clone AC006238 has been mapped to human chromosome 18p11. 2-11.31 , between the markers D18S459 and D18S482, by PCR screening of a human-rodent radiation panel (Fig. 4) . To our knowledge, no male germ cell deficiency or any other type of reproductive anomaly has been reported to map in this region.
Expression of recombinant human Sptrx and enzymatic activity. Recombinant
human Sptrx migrated in SDS-PAGE at 91 kDa size (Fig. 5A ) while its theoretical size is 53 kDa. This retardation in the migration of the protein could be explained by its low pI and net negative charge at neutral pH. In addition, computer analysis of the Sptrx sequence predicts that the N-terminal domain of the protein is organized in α-helical secondary structure which might also contribute to this anomalous migration as described for other testis proteins (23, 24) . Next, we performed PAGE under nondenaturing conditions and human Sptrx migrated at approximately 180 kDa thus suggesting that it might be multimeric in its native state (Fig. 5B) . Preincubation of the protein with DTT did not modify this pattern of migration implying that the multimeric conformation is maintained by non-covalent forces.
Enzymatic activity of thioredoxins is usually assayed by their capacity to reduce the disulfide bonds of insulin using either DTT as artificial reductant or NADPH and thioredoxin reductase as a more physiological reducing system (2) . Figure 6A shows the activity of human recombinant Sptrx with DTT as reducing agent. Surprisingly, the truncated form of Sptrx expressing only the thioredoxin domain did not display a significant activity over the background, suggesting that the active site is buried in this truncated form and only accessible in the full-length form. In another assay where NADPH and calf thymus thioredoxin reductase are used as electron donors for Sptrx, both the full-length and the truncated form are active. Similarly, the truncated form of Sptrx is also less active than the full-length protein indicating that the accessibility of the active site is maintained, at least in part, by the N-terminal domain of Sptrx.
However, the enzymatic activity is higher in the oxidized forms than in the reduced ones in contrast with Trx1 used as control (Fig. 6B ).
Tissue expression, cellular and subcellular localization of human Sptrx. To investigate the expression pattern of Sptrx mRNA, in situ hybridization was performed in human testis sections and showed that it is expressed in round and elongating spermatids with no signal in the rest of the testicular cells (Fig. 7) . Similar results have been obtained in mouse testis sections (M. Pelto-Huikko and A Miranda-Vizuete, unpublished results). Affinity purified antibodies were used to study the expression pattern of Sptrx protein in different human tissues and cell lines. As shown in Figure   8A , only human testis and sperm cell extracts expressed Sptrx as a band of approx. 91 kDa in agreement with the migration of the recombinant protein in SDS gels. No signal was detected in any other tissue or cell line used as control. We also studied the expression of Sptrx in a blot of different human testis and prostate tumours and found no difference with respect to normal tissues (data not shown). Next, we used these antibodies to investigate whether we could identify Sptrx homologues in testis extracts from other mammals. Figure 8B shows that they recognize a similar band in mouse, rat and bovine testis extracts.
The unforeseen result of the sperm-specific localization of human Sptrx prompted us to investigate whether other members of the two thioredoxin systems (cytosolic and mitochondrial) (3, 25) as well as a newly identified thioredoxin reductase highly expressed in testis (26) are present in these cells. We used specific antibodies against all these proteins and by Western blot analysis we were able to identify all of them in both human testis and sperm extracts (Fig. 8C) . To address the question whether Sptrx protein distribution paralleled the mRNA expression, we performed immunohistochemical analysis in human testicular sections that revealed that Sptrx expression was restricted to spermiogenesis and most prominently expressed in round and elongating spermatids. Other cellular types like spermatogonia, primary spermatocytes, Leydig and Sertoli cells were not stained (Fig. 8D) . Identical Sptrx distribution pattern has been observed in rat and mouse testis (R. Oko, M. Pelto-Huikko and A. Miranda-Vizuete, unpublished results). Immunofluorescence of human ejaculated spermatozoa showed that Sptrx was localized from the caudal region of the head to the end of the principal piece (Fig 8E) . However, when using Triton during the fixation protocol this signal was removed thus suggesting that Sptrx is contained (loose) within the tail cytoplasm and the cytoplasmic droplet. To further confirm this point, we performed immunogold electron microscopy analysis in human ejaculated spermatozoa and found that Sptrx is distributed mostly in the cytoplasmic droplet although some scattering of residual labeling was present throughout the sperm tail (Fig 8F-G) . These results in human ejaculated sperm have been also validated for rat, mouse and bull sperm (R. Oko and A. Miranda-Vizuete, unpublished results).
DISCUSSION
During the last five years an increasing number of genes which expression is restricted to spermatogenesis have been reported and the fact that most of their encoded proteins display enzymatic or regulatory properties suggests that they might play a more active role in sperm function than merely structural. In this context, we report here the cloning and characterization of Sptrx, a novel member of the thioredoxin family exclusively expressed in human spermatozoa representing the first mammalian member of the thioredoxin family with a tissue-specific distribution.
Sptrx cDNA was cloned from a human testis cDNA library and both ORF and
UTRs display important features. Analysis of Sptrx ORF identifies a two-domain structure consisting of a N-terminal part organized in 23 repeats of 15 amino acid residues with no homology to any other protein in the databases and a C-terminal domain similar to thioredoxin. Sptrx N-terminus is rich in charged residues and several putative sites for phosphorylation by different kinases can be identified. Among these sites, PKC and casein kinase II appear to be the most likely sites of phosphorylation sites in serine residues. Phosphorylation is one of the major regulatory mechanisms in sperm physiology and practically all the different cellular processes that sperm undergoes e. g. acrosome reaction, capacitation, hyperactivation, motility or binding to egg zona pellucida are mediated by this mechanism (7). In addition, a complete set of different kinases has been identified in mammalian sperm cells both ubiquitous and sperm-specific (27) . Another important feature of the N-terminal domain of Sptrx is the presence of two PEST sequences, which have been reported to be involved in rapid degradation of proteins by the ubiquitin 26S proteasome machinery (28) . Ubiquitindependent degradation has recently been put forward as an important general mechanism for selective degradation of defective sperm along with other contaminants of cellular origin, during epididymal transit (29) . Preliminary experiments show that Sptrx is phosphorylated by PKC and ubiquitinated in vitro (A. Miranda-Vizuete, unpublished results).
The Sptrx gene is organized in two exons separated by one intron located in the 5´-UTR that might be involved in Sptrx regulation as it has been described for other testisspecific proteins (30) . On the other hand, the 3´-UTR is unexpectedly short with only 17 nucleotides and lacking polyadenylation signal, although inspection of the ORF including Sptrx, are testis specific forms. This apparent tissue-specificity may be due to transcriptional promiscuity in testes as the retroposition event is required to occur in the germ line to be fixed in the population (35) .
Sptrx migrates at 180 kDa under non-reducing conditions suggesting a multimeric native conformation. When assayed with calf thymus thioredoxin reductase it can reduce insulin disulfide bridges but this activity is higher in the oxidized form than in the reduced one. This is the first report where a thioredoxin has higher activity in its oxidized form. As noted previously, Sptrx contains four additional cysteine residues that might form intra-or inter-monomeric disulfide bonds therefore stabilizing the
protein. Although Sptrx native conformation is not maintained by disulfide bonds as
shown by non-denaturing gel assay, the decrease of the enzymatic activity after preincubation with a reducing agent indicates that additional cysteine residues in Sptrx modulate its activity. A truncated form of Sptrx lacking the N-terminal domain only displays residual activity implying that the N-terminus is necessary to maintain the accessibility of the active site.
The synthesis of the sperm cytoskeletal polypeptides has been shown to occur in the cytoplasm of elongating spermatids, which is consistent with the expression pattern obtained for Sptrx and corresponds to the growth of the structures that will organize the sperm tail. We have found that all the thioredoxins and thioredoxin reductases so far identified are present in human ejaculated sperm. Thus, although the specific function that they play in spermatozoa is not known, their presence in the mature cell suggests an important role in sperm physiology. Particularly interesting is the presence in sperm of a novel form of thioredoxin reductase that has been found to be highly expressed in testis (26) . This novel TrxR together with Sptrx might constitute the first tissue-specific thioredoxin system, although colocalization of both proteins has not been addressed.
Disulfide bond formation is a very important issue in sperm physiology. The nuclear and accessory structures of mammalian sperm tail become stabilized by extensive disulfide bonding during spermiogenesis and epididymal maturation and this stabilization is reversed during fertilization by the reduction of these disulfide bonds (36, 37) . As we have demonstrated, Sptrx is able to function as a reductant in vitro and displays a spatial and temporal expression in the tail of elongating spermatids which occurs simultaneously with the assembly of ODF and FS. Our data suggests that Sptrx could indeed participate in the regulation of this assembly process by reducing non-correct disulfide pairings thus favouring the generation of the correct disulfide bonds between the different sperm tail constitutents.
In an attempt to identify possible functions of Sptrx in sperm physiology we studied the involvement of Sptrx in the formation of the sperm capsule, a structure that embeds the helix of mitochondria in the middle piece of sperm tail. PHGPx protein represents at least 50% of the capsule material and it is found in an enzymatically inactive, oxidatively cross-linked, unsoluble form (38) . The switch of PHGPx from a soluble active enzyme to an enzymatically inactive structural protein has been shown to occur during differentiation of spermatids into spermatozoa (once the mitochondria have been helically arranged around the axoneme and ODF in the sperm tail middle piece) and to be dependent on thiol groups in proteins distinct from PHGPx (38) .
Despite Sptrx meeting these two criteria, it is not involved in the process as neither the recombinant protein could oxidize soluble PHGPx nor the Sptrx antibodies could prevent aggregation in the presence of hydrogen peroxide (L. Flohé, personal communication).
In conclusion, the identification of Sptrx in human spermatozoa opens up a new dimension within the thioredoxin field. Its expression during sperm tail formation strongly indicates an important role in this process and therefore a potential target for male factor infertility studies. There are numerous reports describing sperm flagellum pathologies for which the molecular bases in unknown. Among those, the best characterized is dysplasia of the fibrous sheath (DFS), a human sperm defect resulting in male sterility that consists of a complete disorganization of this structure which is already evident in spermatids by the loose arrangement of the FS ribs dispersed in the cytoplasmic matrix (39) . The simultaneous expression of Sptrx at the time that FS assembles suggests that there might be a correlation between an anomalous expression of Sptrx and the development of DFS. If so, diagnosis of patients affected with DFS or any other sperm tail pathology might be helped by screening of Sptrx status. 
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